- Q1 2024 OPKO Health Inc Earnings Call TranscriptMay 07, 2024MXN21.5Earnings
- Q4 2023 OPKO Health Inc Earnings Call TranscriptFeb 27, 2024MXN17 (+4.17%)Earnings
- OPKO Health Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 OPKO Health Inc Earnings Call TranscriptNov 06, 2023MXN30Earnings
- Q2 2023 OPKO Health Inc Earnings Call TranscriptAug 03, 2023MXN30Earnings
- Q1 2023 OPKO Health Inc Earnings Call TranscriptMay 03, 2023MXN27.2Earnings
- OPKO Health Inc R&D Day (Virtual) TranscriptMar 20, 2023
- Q4 2022 OPKO Health Inc Earnings Call TranscriptFeb 23, 2023MXN26.81Earnings
- OPKO Health Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 OPKO Health Inc Earnings Call TranscriptNov 08, 2022MXN54.08Earnings
- Q2 2022 OPKO Health Inc Earnings Call TranscriptAug 04, 2022MXN50Earnings
- Q1 2022 OPKO Health Inc Earnings Call TranscriptMay 09, 2022MXN51 (-6.93%)Earnings
- Q4 2021 OPKO Health Inc Earnings Call TranscriptFeb 24, 2022MXN62.2 (+6.31%)Earnings
- OPKO Health Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Q3 2021 OPKO Health Inc Earnings Call TranscriptOct 28, 2021MXN72.61 (-3.70%)Earnings
- Q2 2021 OPKO Health Inc Earnings Call TranscriptJul 29, 2021MXN76.19 (+7.31%)Earnings
- Q1 2021 OPKO Health Inc Earnings Call TranscriptApr 28, 2021MXN85.1 (-1.05%)Earnings
- Q4 2020 OPKO Health Inc Earnings Call TranscriptFeb 18, 2021MXN110 (-6.78%)Earnings
- OPKO Health Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- OPKO Health Inc at Piper Sandler Healthcare Conference (Virtual) - Fireside Chat Pre-Recording Session TranscriptNov 17, 2020
- Q3 2020 OPKO Health Inc Earnings Call TranscriptOct 29, 2020MXN89.52 (+4.09%)Earnings
- Q2 2020 OPKO Health Inc Earnings Call TranscriptJul 30, 2020MXN134.8 (+6.14%)Earnings
- OPKO Health Inc Annual Shareholders Meeting TranscriptJun 25, 2020
- Q1 2020 OPKO Health Inc Earnings Call TranscriptMay 06, 2020MXN55.22Earnings
- Q4 2019 OPKO Health Inc Earnings Call TranscriptFeb 26, 2020MXN29.99Earnings
- OPKO Health Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- OPKO Health Inc at Piper Jaffray Healthcare Conference TranscriptDec 04, 2019
- Q3 2019 OPKO Health Inc Earnings Call TranscriptNov 05, 2019MXN41.6Earnings
- Q2 2019 OPKO Health Inc Earnings Call TranscriptAug 07, 2019MXN38.53Earnings
- OPKO Health Inc Annual Shareholders Meeting TranscriptJun 20, 2019
- Q1 2019 OPKO Health Inc Earnings Call TranscriptMay 07, 2019MXN47Earnings
- Q4 2018 OPKO Health Inc Earnings Call TranscriptFeb 27, 2019MXN51.5Earnings
OPKO Health Inc at Piper Sandler Healthcare Conference (Virtual) - Fireside Chat Pre-Recording Session Transcript
(technical difficulty)
analyst at Piper Sandler. Welcome to Piper Sandler's Virtual Health Care Conference. OPKO is a diversified health care company comprised of BioReference Labs, GeneDx and a fully integrated pharmaceutical business. BioReference has served an important role in the pandemic with SARS-CoV-2 PCR and antibody testing.
On the pharmaceutical side, we're awaiting Pfizer's submission of a BLA for somatrogon, a once-weekly human growth hormone. Online from OPKO is Steve Rubin, who's Executive Vice President and Administrative; Jon Cohen, Executive Chairman of BioReference; and Adam Logal, who's the CFO. Thanks for joining us, guys.
Questions & Answers
Jon, I'm going to start off and -- with you. And first and foremost, I just want to say thank you to you and everybody at BioReference for what you guys are doing during
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)